logo
calendar26 Yanvar 2021
view32
Main language:Russian

ИССЛЕДОВАНИЕ АНТИКОАГУЛЯНТНОЙ АКТИВНОСТИ МОДИФИЦИРОВАННЫХ ПОЛИСАХАРИДА

Field of Science:
pdf

file.pdf

PDF

Scientific Bulletin of Namangan State University

Scientific Bulletin of Namangan State University

Publish Articlesee more

ARTICLE ANNOTATION

quote
The effect of a chemical modified sulfated polysaccharide in experiments on human bloodplasma in vitro on the hemostasis system was studied. The effect of in vitro compounds with various tests on APTT, prothrombin time, and thrombin were studied. In this case, the anticoagulant activity was established. The polysaccharide in the body exhibits a combined anticoagulant effect, due to which they belong to anticoagulant and antithrombin agents.

AUTHORS

N.Khoshimov

K.Nasirov

B.Muhitdinov

V.Azizov

Tags

# антикоагулянты крови# плазма человека# антитромбин# қон антикоагулянтлари# одам плазмаси# blood anticoagulants# human plasma# antithrombin

OTHER ARTICLES IN THIS JOURNAL

Rate Article

0
0 ratings
5
4
3
2
1

Article Identifiers

ROI:

https://eroi.uz/11.0031/A0121-0292

DOI:

Not Available

References

Geerts W. Prevention of venous thromboembolism: American College of Chest Physicians evidence-based clinical practice guidelines (8th Edition)/ W. Geerts, D Bergqvist, G.F. PineoJ.A. Heit, C.M. Samama, M.R. Lassen, C.W. Colwell // Chest. - 2008. - 133 (6). - P.381S-453S.

Ageno W. Antithrombotic treatment of splanchnic vein thrombosis: results of an international registry / W Ageno, N Riva, S Schulman, et al. // SeminThrombHemost. - 2014.- Feb;40(l). - P.99-105.

Molteni M. Warfarin and atrial fibrillation: from ideal to real the warfarin affaire/ M. Molteni, C. Cimminiello // Thromb J. - 2014. - 12(1). - P.5.; VoT., 2014.

Vo T. Current state of anticoagulants to treat deep venous thrombosis / T. Vo, S. Vazquez, M.T. Rondina // CurrCardiol Rep. -2014. -16(3). -P.463.

Verhaeghe R., DeMoerloose P., Eikenboom J.C. et al. Genetic and asquired risk factors of venous thromboembolism. In: Pulmonary Vascular Pathology: A Clinical Update. Eds. M. Demedts, M. Delcroix, R. Verhaeghe, G.M. Verleden. EurRespSoc 2004. –С. 9.

Wang Z.M., Li L., Zheng B.S., Normakhamatov N., GuoS.Y. Preparation and anticoagulation activity of sodium cellulose sulfate // Int. J. Biol. Macromol. 2007. Vol.41 (2). -P. 376-382.

Huynh R., Chaubet F., Jozefonvicz J. Anticoagulant properties of dextranmethylcarboxylatebenzylamide sulfate (DMCBSu); a new generation of bioactive functionalized dextran // Carbohydr. Res. 2001. Vol. 332. -P. 75-83. 10.

Mahner C., Lechner M. D., Nordmeier E. Synthesis and characterization of dextran and pullulan sulphate // Carbohydr. Res. 2001. Vol. 331. -P. 203-208.